Podcasts about Kidney transplantation

We are giving you a fresh take on celebrity health news and medical news that you can't get anywhere else! We're talking about Al B. Sure!'s wild survival story (coma, liver transplant, and those Diddy rumors), plus Nate Robinson's journey from NBA All-Star to kidney transplant survivor.I misspoke on the LIVE today. I said that it is standard of care for one to be referred to a nephrologist when the eGFR is less than 30. I meant to say that it is standard of care to refer a patient to a nephrologist when the eGFR is less than 60 and when the patient is in stage 3 CKD.This podcast is intended to be informational only.  It is not a medical consultation, nor is it personalized medical advice.  For medical advice, please consult your physician.Did you hear about Fox News commentator Camryn Kinsey fainting on live TV? Let's talk about why fainting happens—and why it's not just about “catching your breath.” Also, have you heard about That's So Raven, Disney Star, Rondell Sheridan's pancreatitis battle? It's a wake-up call for sure, and we'll talk about what you need to know plus so much more!#HealthHappyLifePodcast #DrFrita #MedicalMondays #MedicineInTheNewsHere are a few helpful resources to help on your journey to wellness:▶️ Subscribe so you will never miss a YouTube video.

It's Episode 16 of The Nephron Segment and it's time for NephMadness! Join us as we chat with transplant nephrologist Dr. Swee Levea & transplant surgeon (and obesity medicine specialist!) Dr. Babak Orandi and discuss the obesity in kidney transplant recipients and kidney transplant donors! Listen to the end to hear everyone's picks (except any Blue Ribbon Panelists) for NephMadness 2025. Before you make your picks, check out the Obesity & Kidney Transplant Region here. Or flip a coin.Submit your NephMadness brackets here (just like March Madness!) by 3/31. Maximize your changes by submitting 2 brackets per email address.Nephrons: Matthew Sparks, Samira FaroukGuests: Swee Levea, Babak Orandi

Nephrologist Manjula Tamura discusses the downsides of kidney dialysis, especially for old or frail patients. Her field has set its sights on offering alternatives, including supportive medical management without dialysis, dialysis in increments, wearable artificial kidneys, and transplanted kidneys from genetically modified pigs – in addition to advances in preventive care that can help humans avoid kidney failure in the first place. Dialysis can extend life, she says, but it is a lifestyle change. The goal is to ensure that every patient's choice aligns with their values and life goals, Tamura tells host Russ Altman in this episode of Stanford Engineering's The Future of Everything podcast.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your quest. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Manjula Kurella TamuraConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest, Manjula Tamura, a professor of medicine and nephrology at Stanford University Medical School.(00:02:58) The Kidney's Vital RoleThe kidney's role and why its failure is life-threatening.(00:04:51) Causes of Kidney FailureThe leading causes of kidney failure in developed countries.(00:07:58) Kidney TransplantationThe feasibility, barriers, and supply challenges of kidney transplantation.(00:09:50) The Dialysis ProcessHow hemodialysis and peritoneal dialysis work and patient experiences.(00:14:07) The Evolution of Dialysis TreatmentThe history of dialysis and how Medicare's expansion influenced its use.(00:18:48) Study Design: Emulating Clinical TrialsUsing VA electronic health records to simulate trials on dialysis.(00:25:31) Findings: Survival vs. Time at HomeThe trade-offs between extended survival and reduced time at home.(00:27:02) Quality of Life and DialysisMeasuring quality of life impacts through electronic health records.(00:30:32) The Future of Kidney TreatmentsInnovations like xenotransplantation and wearable artificial kidneys.(00:33:04) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook

Alice Sheridan, MD, FASN, and Martina McGrath, MD, FASN, speak with guest editors Sumit Mohan, MD, MPH, FASN, and Winfred Williams, MD, to discuss "Racial Inequalities in Access to Kidney Transplantation" from nephSAP Vol. 23, No. 5, Transplantation.

Alice Sheridan, MD, FASN, and Martina McGrath, MD, FASN, speak with guest editors Sumit Mohan, MD, MPH, FASN, and Winfred Williams, MD, to discuss "Racial Inequalities in Access to Kidney Transplantation" from nephSAP Vol. 23, No. 5, Transplantation.

View Activity Information Download Slides…

Show Notes: Dr. Satish Nadig with Northwestern Medicine and kidney transplant recipient, John Nicholas, join us to share details about a medical breakthrough in kidney transplantation. The AWAKE Kidney Program (Accelerated Surgery Without General Anesthesia in Kidney Transplantation) is a new approach in kidney transplantation, and in John's case, the 28-year-old was discharged less than 24 hours after surgery and continues to do well. We learn how the process was developed and how it could make kidney recipients' surgical recovery more manageable. In our Mental Health Moment, we discuss how to thoughtfully evaluate emotions and then honor donor hero, Christine McKey.

In an analysis of patients undergoing kidney transplantation, depression and health related quality of life were measured at 3-months and 1-year post-transplantation. Depression and HRQOL improve with KT.

In 'Episode 1' of the series on "Voices of tomorrow's urologists (ESRU): Journeying through Europe's resident perspectives", Dr. Vital Hevia Palacios and Dr. Alessio Pecoraro discuss "Into the OR: Residents' role in kidney transplants". This episode takes a look at the valuable contributions urology residents can make during kidney transplant surgeries. Dr. Hevia Palacios and Dr. Pecoraro share their firsthand experiences, shedding light on the challenges and opportunities that come with this vital training. Their conversation provides insights into the evolving role of residents in transplantation, highlighting the importance of hands-on experience in shaping the next generation of urologists.

In this episode, Dr. Mo explores the transformative power of kidney transplantation. He delves into the benefits and key considerations, outlines the essential steps involved in the transplant process, and discusses the potential costs associated with this life-saving procedure. - The Kidney Zone Podcast with Dr. Mo Welcome to the Kidney Zone, where we will dive deep into the fascinating world of our body's remarkable filters. Get ready to unlock the secrets of the kidneys and transplantation as we travel through their pathways, uncovering vital tips, insightful knowledge, and practical advice to keep our kidneys healthy. Whether you're a patient with kidney disease, a medical professional, or simply curious about the kidneys, this is the place for you. _ Follow Along on Social Media: Facebook: https://www.facebook.com/Dr.Mo.Page Instagram: https://www.instagram.com/dr.mo.ibrahim/ Twitter: https://twitter.com/drmoibrahim TikTok: https://www.tiktok.com/@dr.mo.ibrahim _ Dr. Mo Ibrahim is an assistant professor of kidney transplantation at the University of Maryland, Baltimore. He completed his clinical transplant nephrology fellowship at Washington University in 2022. Originally from Cairo, he pursued a physician/scientist career, conducting research at Duke University from 2012 to 2019. He has authored 70+ journal articles, given a TEDx talk, and holds 5 patents. Currently finishing his PhD at Erasmus University, he drives international collaborations to advance medical technology and improve medical monitoring. _ DISCLAIMER The content of this episode is intended for informational purposes only and is not to be considered medical advice. The information presented here is not meant to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare professional or your doctor before making any healthcare decisions or starting any treatment regimen. Individual medical situations can vary, and only a licensed healthcare provider can offer personalized advice tailored to your specific needs. The creators of this episode are not responsible for any actions taken based on the information provided herein. Any reliance on the content of this episode is at your own risk. If you have any medical concerns or questions, please seek guidance from a medical professional promptly. Remember that medical knowledge and practices can evolve over time, and new information may become available after the creation of this episode. Therefore, it is essential to stay up-to-date with the latest medical research and consult with your healthcare provider to ensure the best possible care for your health.

In this episode we're diving into an important topic that offers hope and new possibilities for those with end-stage renal disease (ESRD): "Life After Dialysis: Exploring Kidney Transplantation and Other Treatment Options." Over the next 15 minutes, we'll explore the benefits and challenges of kidney transplantation, alternative treatments, and how to make informed decisions for a healthier future. - The Kidney Zone Podcast with Dr. Mo Welcome to the Kidney Zone, where we will dive deep into the fascinating world of our body's remarkable filters. Get ready to unlock the secrets of the kidneys and transplantation as we travel through their pathways, uncovering vital tips, insightful knowledge, and practical advice to keep our kidneys healthy. Whether you're a patient with kidney disease, a medical professional, or simply curious about the kidneys, this is the place for you. _ Follow Along on Social Media: Facebook: https://www.facebook.com/Dr.Mo.Page Instagram: https://www.instagram.com/dr.mo.ibrahim/ Twitter: https://twitter.com/drmoibrahim TikTok: https://www.tiktok.com/@dr.mo.ibrahim _ Dr. Mo Ibrahim is an assistant professor of kidney transplantation at the University of Maryland, Baltimore. He completed his clinical transplant nephrology fellowship at Washington University in 2022. Originally from Cairo, he pursued a physician/scientist career, conducting research at Duke University from 2012 to 2019. He has authored 70+ journal articles, given a TEDx talk, and holds 5 patents. Currently finishing his PhD at Erasmus University, he drives international collaborations to advance medical technology and improve medical monitoring. _ DISCLAIMER The content of this episode is intended for informational purposes only and is not to be considered medical advice. The information presented here is not meant to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare professional or your doctor before making any healthcare decisions or starting any treatment regimen. Individual medical situations can vary, and only a licensed healthcare provider can offer personalized advice tailored to your specific needs. The creators of this episode are not responsible for any actions taken based on the information provided herein. Any reliance on the content of this episode is at your own risk. If you have any medical concerns or questions, please seek guidance from a medical professional promptly. Remember that medical knowledge and practices can evolve over time, and new information may become available after the creation of this episode. Therefore, it is essential to stay up-to-date with the latest medical research and consult with your healthcare provider to ensure the best possible care for your health.

View Activity Information…

Host Roz is joined by AJT Executive Guest Editor Nadim Mahmud, MD, MPH (University of Pennsylvania) and AJT Editorial Fellow Tina Marinelli, MBBS, MPH&TM,  FRACP (Royal Prince Alfred Hospital).   [03:10] Semidirected Living Donors in Israel: Sociodemographic Profile, Religiosity, and Social Tolerance   [11:54] TCRseq Reveals Selected Donor-reactive CD8+ T cell Clones Resist Anti-Thymocyte Globulin Depletion after Kidney Transplantation   [18:47] Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation   [26:36] Surgical site infections after kidney transplantation are independently associated with graft loss   [38:26] Introduction to Virtual Special Issue, Insights into ACLF: From Pathogenesis to Interventions   [39:21] Immunopathogenesis of acute on chronic liver failure   [43:43] Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm!

More than 100,000 people in the U.S. need an organ transplant, but there is a shortage of donors. Could the solution be found in pigs? The early success of the first transplant of a pig kidney into a living human points to a future when xenotransplantation could be routine.

Rachel Meyer the Strategic Policy Advisor at the American Society of Nephrology and Sharon Pearce, Senior Vice President of Governance Affairs at National Kidney Foundation discuss the changes in U.S. policy regarding organ transplantation.   Organ Procurement and Transplantation Network (OPTN) Modernization Initiative: https://www.hrsa.gov/optn-modernization “Dialysis Facility Profit Status and Early Steps in Kidney Transplantation in the Southeastern United States” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216615/ “Disparities in kidney transplant waitlisting among young patients without medical comorbidities” https://pubmed.ncbi.nlm.nih.gov/37782509/ “Patient Preferences for Waiting Time and Kidney Quality” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625104/ H.R.2923 - Living Donor Protection Act of 2023: https://www.congress.gov/bill/118th-congress/house-bill/2923?s=1&r=9 National Living Donor Assistance Center (NLDAC): https://www.livingdonorassistance.org/ H.R.6171 - Living Organ Donor Tax Credit Act of 2023:  https://www.congress.gov/bill/118th-congress/house-bill/6171  

Does kidney transplantation cure chronic kidney disease? Today, we will explore  kidney transplantation for chronic kidney disease: "Kidney Transplantation for Chronic Kidney Disease. We'll dive into the transformative potential of kidney transplantation, examining its benefits, considerations, and implications for individuals living with chronic kidney disease. _ The Kidney Zone Podcast with Dr. Mo Welcome to the Kidney Zone, where we will dive deep into the fascinating world of our body's remarkable filters. Get ready to unlock the secrets of the kidneys and transplantation as we travel through their pathways, uncovering vital tips, insightful knowledge, and practical advice to keep our kidneys healthy. Whether you're a patient with kidney disease, a medical professional, or simply curious about the kidneys, this is the place for you. _ Follow Along on Social Media: Facebook: https://www.facebook.com/Dr.Mo.Page Instagram: https://www.instagram.com/dr.mo.ibrahim/ Twitter: https://twitter.com/drmoibrahim TikTok: https://www.tiktok.com/@dr.mo.ibrahim _ Dr. Mo Ibrahim is an assistant professor of kidney transplantation at the University of Maryland, Baltimore. He completed his clinical transplant nephrology fellowship at Washington University in 2022. Originally from Cairo, he pursued a physician/scientist career, conducting research at Duke University from 2012 to 2019. He has authored 70+ journal articles, given a TEDx talk, and holds 5 patents. Currently finishing his PhD at Erasmus University, he drives international collaborations to advance medical technology and improve medical monitoring. _ DISCLAIMER The content of this episode is intended for informational purposes only and is not to be considered medical advice. The information presented here is not meant to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare professional or your doctor before making any healthcare decisions or starting any treatment regimen. Individual medical situations can vary, and only a licensed healthcare provider can offer personalized advice tailored to your specific needs. The creators of this episode are not responsible for any actions taken based on the information provided herein. Any reliance on the content of this episode is at your own risk. If you have any medical concerns or questions, please seek guidance from a medical professional promptly. Remember that medical knowledge and practices can evolve over time, and new information may become available after the creation of this episode. Therefore, it is essential to stay up-to-date with the latest medical research and consult with your healthcare provider to ensure the best possible care for your health.

Over one million people in the U.S. grapple with HIV. Although life expectancy has increased, end-stage organ diseases have a relatively high mortality rate for these patients. Learn about HIV-to-HIV kidney transplants from Shikha Mehta, M.D., director of the UAB HIV and Hepatitis C Transplant Program. She explains how her interdisciplinary team has made successful kidney transplants for over decade despite numerous challenges and comorbidities of those with HIV.   Disclosure InformationRelease Date: February 19, 2024Expiration Date: February 18, 2027 Planners:Ronan O'Beirne, EdD, MBA | Director, UAB Continuing Medical EducationKatelyn Hiden | Physician Marketing Manager, UAB Health SystemThe planners have no relevant financial relationships with ineligible companies to disclose. Faculty:Shikha Mehta, MD | Medical Director, Kidney and Pancreas Transplant ProgramDr. Mehta has no relevant financial relationships with ineligible companies to disclose. There is no commercial support for this activity.

This podcast episode examines the need for and promise of xenotransplantation, considering first the plight of patients and then the progress being made by researchers. . Is Xenotransplantation Ready for Prime Time? N Engl J Med 2023;389:e49.

Amy Waterman directs the Transplant Research and Education Center at UCLA. She works with patients navigating any disease of the kidney and helps educate them on corresponding choices, from dialysis treatment to getting on a transplant list. She discusses: How the general process works as a patient enters their center, from considering treatment options to seeking a donor, What the statistics are in the donor-transplant relationship and the range of donor options, and How the physical process works for transplantation and what are risk factors compared to the dialysis process. In addition to directing the Transplant Center, Amy D. Waterman is a Professor in Residence at the University of California in Los Angeles in the division of nephrology. She's a psychologist with an expertise on managing patient behavior toward healthy goals. At the center, she works alongside nephrologists and other professionals to guide patents through choices and the complicated process of facing kidney disease. She researches and tests methods that might help educate and engage patients and evaluates how to work more effectively with providers. online pharmacy buy neurontin over the counter online pharmacy She describes for listeners the process a patient moves through, from typical questions they have to choices they can make, and for those that need a transplant, how to enter into searches for a donation from family members to strangers to someone who has passed away. She adds that there is a donor contingent called non-directed donors. online pharmacy buy singulair over the counter online pharmacy These are strangers who step forward and offer a kidney as a living donor. online pharmacy buy clomiphene over the counter online pharmacy In fact, over 6,000 living people donate a kidney each year. Dr. Waterman also describes the physical process of donation, what might be in the works for kidney disease cures, and how she became involved with this important work in the first place.  Find out more about her work at exploretransplant.org or explorelivingdonation.org. Available on Apple Podcasts: apple.co/2Os0myK

The Filtrate:Joel TopfSwapnil HiremathSophia AmbrusoAC GomezWith Special Guest:Amit Garg (@AmitXGarg) Nephrologist at Western University, London, and lead PI of the EnAKT LKD trial. Susan Q. McKenzie (LinkedIn) Co-Founder & Chair, Transplant Ambassador Program. President of the Kidney Patient and Donor Alliance of Canada.Editor:Joel TopfShow Notes:Late Braking and High Impact Clinical Trial press releaseJAMA Internal MedicineMyTEMP trial Personalised cooler dialysate for patients receiving maintenance haemodialysis (MyTEMP): a pragmatic, cluster-randomised trial (PubMed | NephJC | Freely Filtered)Transplant is cheaper! An economic assessment of contemporary kidney transplant practice (PDF)Transplant is better! Survival for waitlisted kidney failure patients receiving transplantation versus remaining on waiting list: systematic review and meta-analysis (PubMed)Transplant disparities Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014 (PubMed)MUC1 Kidney Disease Autosomal Dominant Tubulointerstitial Kidney Disease: An Emerging Cause of Genetic CKD (Kidney International Reports)This study has all the adjectives: “We conducted a pragmatic, two-arm, parallel-group, open-label, registry-based, superiority, cluster- randomized clinical trial.”Explore Transplant by Amy Waterman, PhDTransplant Ambassador ProgramKidney Failure Risk Equation A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure (JAMA | Calculator)The complete protocol A Quality Improvement Intervention to Enhance Access to Kidney Transplantation and Living Kidney Donation (EnAKT LKD) in Patients With Chronic Kidney Disease: Clinical Research Protocol of a Cluster-Randomized Clinical Trial (PDF)Pre-published statistical plan Enhance Access to Kidney Transplantation and Living Kidney Donation (EnAKT LKD): Statistical Analysis Plan of a Registry-Based, Cluster-Randomized Clinical Trial (PubMed)Hawthorne effect (Wikipedia)The Advancing American Kidney Health Initiative “Aim for 80% of new American ESRD patients in 2025 receiving either home dialysis or a transplant” (NKF)Tubular SecretionsSwapnil The Time Travelers Wife by Audrey Niffenegger (Wikipedia) and HBO movie of the same name (Wikipedia).Sophia The Wheel of Time streaming on Amazon (Wikipedia) based on the series of books of the same name by Robert Jordan and Brandon Sanderson.Susan The Woman Who Loved Giraffes movie (Website)Amit Canadians cannot get Visas to visit India (Reuters)AC Eagles are good at Football (Fox Sports) and Alport Connect Meeting in San Diego (Alport Syndrome Foundation Website)Joel Live podcast recording at Kidney Week (NephJC)

CJASN Editor-in-Chief Rajnish Mehrotra interviews Tristan de Nattes, the 2023 CJASN Trainee of the Year second-place winner, on his article, "A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies."

Join experts Drs Matthew Sparks and Samira Farouk as they pull back the curtain to help patients and providers better understand the transplant journey. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991605). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric Transplant https://pubmed.ncbi.nlm.nih.gov/10580071/ Metabolic Disorders Following Kidney Transplantation https://pubmed.ncbi.nlm.nih.gov/22445053/ Cardiac Evaluation of the Kidney or Liver Transplant Candidate https://pubmed.ncbi.nlm.nih.gov/33315765/ About the Zweig Family Center for Living Donation https://www.mountsinai.org/care/transplant/services/living-donor/zweig Social Determinants of Health and Race Disparities in Kidney Transplant https://pubmed.ncbi.nlm.nih.gov/33509963/ The Race Coefficient in Glomerular Filtration Rate-Estimating Equations and Its Removal https://pubmed.ncbi.nlm.nih.gov/36093899/ Organ Procurement and Transplantation Network https://optn.transplant.hrsa.gov/ Transplant Renal Artery Stenosis: Current Concepts https://pubmed.ncbi.nlm.nih.gov/36718003/ Renal Transplantation: Technical Aspects, Diagnosis and Management of Early and Late Urological Complications https://pubmed.ncbi.nlm.nih.gov/24637470/ Saving Lives With Nirmatrelvir/Ritonavir One Transplant Patient at a Time https://pubmed.ncbi.nlm.nih.gov/36847419/ Society for Maternal-Fetal Medicine Consult Series #66: Prepregnancy Evaluation and Pregnancy Management of Patients With Solid Organ Transplant https://pubmed.ncbi.nlm.nih.gov/37088276/

In this podcast, EIC Josie Briggs talks with Associate Editor John Gill about the valuable data resources for research on kidney transplantation. Drs. Gill and Briggs provide some advice for users of these important resources.

The Word on Medicine has a wonderful program this week – and it is all about Kidney Transplantation. Our all-star cast includes Dr. Matthew Cooper, Chief of Transplantation; Alyssa Rutledge, Registered Nurse and Kidney/Pancreas Transplant Coordinator; Dr. Rima Patel, Medical Director of Kidney and Pancreas Transplantation in the Division of Nephrology; and Ami Blatter, a Registered Nurse and Living Kidney Donor Transplant Coordinator. Most importantly, we have two amazing patients - Mark & Stacy (recipient and donor of a kidney transplant – and husband and wife). You do not want to miss their heartwarming story in our fact-filled program!

Mr. Pierre Giguère and Dr. Swapnil Hiremath provide an overview of their study, "Management and Outcome of COVID-19 Infection Using Nirmatrelvir/Ritonavir in Kidney Transplant Patients," on behalf of their colleagues.

Mr. Pierre Giguère and Dr. Swapnil Hiremath provide an overview of their study, "Management and Outcome of COVID-19 Infection Using Nirmatrelvir/Ritonavir in Kidney Transplant Patients," on behalf of their colleagues.

In the United States today, there are over 110,000 people waiting for an organ transplant. And, Dr. Sandip Kapur says, 92% of those patients are waiting for a kidney. In this episode, Dr. Kapur describes a simple philosophy that helped guide Weill Cornell Medicine into one of the top kidney transplantation centers in the nation: offer the maximum amount of opportunities to transplantation that could exist. That means working with multidisciplinary teams to innovate every step of the kidney transplantation process– from making donor surgeries minimally invasive, to matching donors and recipients in new ways through the National Kidney Registry, and even pioneering research into immunotherapy, to improve success rates and patients' quality of life post-surgery.For more information visit nyp.org/Advances

Drs. Calyani Ganesan, Alan Pao, and John Leppert discuss the results of their study, "Kidney Stone Events after Kidney Transplant in the United States," on behalf of their colleagues.

Drs. Calyani Ganesan, Alan Pao, and John Leppert discuss the results of their study, "Kidney Stone Events after Kidney Transplant in the United States," on behalf of their colleagues.

In this episode, Dr Jamie Coleman is joined by Bradley Kushner, MD, from the Washington University School of Medicine, St Louis. They discuss Dr Kushner's study, which found that patients who are unvaccinated against COVID-19 have worse compliance and healthcare follow-up after a kidney transplant compared with those who were preoperatively vaccinated.   Disclosure Information: Drs Kushner and Coleman have nothing to disclose.   To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date. Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more. #JACSOperativeWord

David White speaks with ASN President Michelle A. Josephson, MD, FASN, and ASN Strategic Policy Advisor to the Executive Vice President Rachel Meyer about changes within HRSA, big-picture issues within transplant nephrology, and more.

David White speaks with ASN President Michelle A. Josephson, MD, FASN, and ASN Strategic Policy Advisor to the Executive Vice President Rachel Meyer about changes within HRSA, big-picture issues within transplant nephrology, and more.

Dr. Tristan de Nattes discusses the results of his study "A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies," on behalf of his colleagues.

Dr. Tristan de Nattes discusses the results of his study "A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies," on behalf of his colleagues.

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Alexandra Benachi, MD, PhD Guest: Julien Zuber, MD, PhD Program Chairman:Roberto Romero, MD, DMedSciChief, Perinatology Research BranchDivision of Maternal-Fetal Medicine and ObstetricsDivision of Intramural ResearchNICHD/NIH/DHHSEditor-in-Chief for ObstetricsThe American Journal of Obstetrics and Gynecology There exists a long-standing controversy about drawing parallels between transplant and pregnancy immunology. Listen in as Drs. Alexandra Benachi, Julien Zuber, and Lee Shulman discuss why these considerations are so important for you and your colleagues, patients, and their families to understand. Discover how links between kidney transplantation and maternal anti-fetal rejection may impact your practice and spark new pathways in medicine.

CME credits: 0.25 Valid until: 28-02-2024 Claim your CME credit at https://reachmd.com/programs/cme/parallels-between-kidney-transplantation-and-maternal-anti-fetal-rejection/13911/ Program Chairman:Roberto Romero, MD, DMedSciChief, Perinatology Research BranchDivision of Maternal-Fetal Medicine and ObstetricsDivision of Intramural ResearchNICHD/NIH/DHHSEditor-in-Chief for ObstetricsThe American Journal of Obstetrics and Gynecology There exists a long-standing controversy about drawing parallels between transplant and pregnancy immunology. Listen in as Drs. Alexandra Benachi, Julien Zuber, and Lee Shulman discuss why these considerations are so important for you and your colleagues, patients, and their families to understand. Discover how links between kidney transplantation and maternal anti-fetal rejection may impact your practice and spark new pathways in medicine.=

Commentary by Dr. Valentin Fuster

Texas statewide has a real issue with maternal mortality, up to even a year after giving birth. Cardiovascular disease is often a contributor, and that can lead to preeclampsia, or dangerously high blood pressure during pregnancy or after delivery. Theresa Patton, MD, OB-GYN at Methodist Dallas Medical Center joins us to discuss what women can do to prevent or treat this serious condition. Next, there is a way you can give the gift of life to a friend, relative, or even a total stranger. It is through Living Donor Kidney Transplantation. Dr. Johanna Bayer, MD, Abdominal Transplant Surgeon at Baylor Scott & White All Saints Medical Center in Fort Worth explains. Working in healthcare can be one of the most rewarding careers available. Helping others, whether from the clinical side as a physician, nurse or therapist, or from the administrative side as a manger, CEO, or simply working in housekeeping, hospitals are a “city within a city.” Natalie Wilkins, Chief of Staff to the President and CEO at Cook Children's Health Care System talks to us about her job and the landscape of working in healthcare.

How do you talk to patients about kidney health, lifestyle risks, or a plan for transplantation? In this episode, Drs Sparks, Diamantidis, and Farouk discuss the science, current studies, and their clinical experience. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/971888). The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US healthcare professionals. Resources Kidney Transplantation https://emedicine.medscape.com/article/430128-overview Kidney Transplantation https://www.medscape.com/viewarticle/443490_5 The Advancing American Kidney Health Initiative https://www.kidney.org/advocacy/advancing-american-kidney-health-initiative System Interventions to Achieve Early and Equitable Transplants (STEPS) Study https://clinicaltrials.gov/ct2/show/NCT05014256?titles=system+interventions+to+achieve+early+and+equitable+transplants&draw=2&rank=1 Evaluation for Kidney Transplant https://www.kidney.org/atoz/content/kidney-transplant-evaluation What Do Acute Kidney Injury Survivors Want to Know About Their Condition: A Qualitative Study https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044096/

Dr. Raja Dandamudi summarizes the results of his study "Longitudinal Evaluation of Donor-Derived Cellfree DNA in Pediatric Kidney Transplantation," on behalf of his colleagues.

Dr. Tim Knobbe summarizes the results of his study "Employment Status and Work Functioning among Kidney Transplant Recipients," on behalf of his colleagues.

0:00 Intro 3:20 Being a protege in everything and joining IIT 6:35 Physical health deteriorates and body turns yellow 8:11 Blood tests show 90% Kidney failure 10:00 When Dr. Sandeep gives motivation to keep going and gets a kidney from his mom 12:20 Deciding to for IIT exam even after being on immunosuppressants 14:30 When grace works for IIT 20:30 Joining college and just sitting and grinning in class and enjoying life 23:19 How he across Sandeep Maheshwari after getting bullied 25:30 Interest in Vipassana starts and parents were not so happy but still going for Vipassana 29:00 Sixth day is the hardest in vipassana 31:00 The comment from Guruji that broke Saurabh Anna 34:00 Completing vipassana from Varanasi centre. 36:00 Learning 5 years of music in 6 months 37:00 Learning piano classes from Hasit nanda the Piano sensation of India 41:00 Getting a piano from the money from a website which was previously not making any money 43:00 Sadhguru enters 45:30 Playing music which is mathematically simple and very perfect 50:40 Going for Mahashivratri in coimbatore 53:00 Deciding to do inner engineering with his new spiritual friend 54:00 Sharing his most vulnerable experience of being in a relationship 58:00 Twin flames 1:01:52 Bhrigu story 1:04:00 The bad effects of twin flame relationships 1:08:00 how twin flame relationships work 1:13:00 Slowly health deteriorates again 1:23:00 How Saddhgurus Intervention gave him back his life 1:30:00 Life right now with dialysis and the most important thing which he has lost 1:33:01 we can all take a second to reflect on the blessings in our lives listeners 1:36:00 Meeting Sadhguru for save soil event even with all the problems 1:42:00 Wanting to join Sounds of Isha 1:44:00 Final words 1:45:00 To be able to drink water whenever I want Connect with me and an awesome community on Discord: https://discord.gg/quazmzdf87

Guest: Carrie A. Schinstock, M.D. (@caschinstock) Host: Darryl S. Chutka (@ChutkaMD) Kidney transplants were initially performed in the early 1950's; however, most of these early transplants failed due to immune system rejection. Successful transplants were generally limited to those performed in identical twins. With the discovery of immunosuppressant therapy, organ rejection became less of an issue and successful kidney transplants have become more common. Currently, in the U.S. over 20,000 kidney transplants are performed annually. Who is a candidate for a kidney transplant? What is the current success rate and what is the optimal timing for a transplant in patients with end stage renal disease? We'll discuss these questions in this podcast on kidney transplantation with our guest, Carrie A. Schinstock, M.D., a nephrologist from the Division of Nephrology and Hypertension at the Mayo Clinic. Connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Drs. Mark Lambie, Jeff Perl, and Jenny Shen summarize the results of their study "Variation in Peritoneal Dialysis Time on Therapy by Country," on behalf of their colleagues.

Dr. Richard Pierson is the scientific director of the Massachusetts General Hospital Center for Transplantation Science and a professor of surgery at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R.N. Pierson III. Progress toward Pig-to-Human Xenotransplantation. N Engl J Med 2022;386:1871-1873.

Conversation w/ Jennifer Verbesey, MD, Director, Living Donor Kidney Transplantation, MedStar Georgetown University Hospital Transplant Institute, about kidney disease and aging, and kidney transplantation including donor/recipient evaluation, compatibility, and eligibility.

Dr. Jeanine Cook-Garard learns about your kidneys - why they are so important to our overall health, and the options you have when they may have a health problem. Her guest is Dr. Vinay Nair, the Medical Director of Kidney Transplantation at Northwell Health, and Associate Professor of Medicine and Surgery, in the Division of Kidney Diseases and Hypertension, at the Zucker School of Medicine at Hofstra Northwell.

Pregnancy can be an exciting time for most people, but what does it look like if you are a kidney patient? What does pregnancy look like if they have kidney disease, are on dialysis, or have received a transplant? In this episode, we'll hear useful facts and tips from transplant nephrologist Dr. Mariana Markell, as well as personal stories from Cari Maxwell and Katie Reed, two mothers living with kidney disease.   In this episode, you'll hear from: Dr. Mariana Markell  Dr. Markell is a graduate of Yale University and New York Medical College and received her Residency and Fellowship training at Columbia-Presbyterian Hospital and UCLA Medical Center. At SUNY Downstate she has served as the Director of Inpatient Dialysis and created the first Transplant Nephrology Fellowship Program in New York City. She currently continues to care for general and transplant nephrology patients while serving at the Medical Director of Kidney Transplantation. Her research interests include the impact of social determinants of health and issues in women's health in the person with kidney disease. Katie Reed Katie Reed has autosomal dominant tubulointerstitial MUC1 kidney disease (ADTKD-MUC1) and is a recent recipient of a successful kidney transplant. Katie is a board member for the Rare Kidney Disease Foundation, which focuses on raising awareness of ADTKD, building up the ADTKD community, and advocating for patients and families. Katie and her husband reside in North Carolina and are parents to two young children. In their free time, you can find the Reeds out and about at local parks, watching a thrilling game of preschool-aged soccer, cheering for the Steelers, or taking over Disney World in matching family shirts. Professionally, Katie is a Managing Director with Afton Partners, a consultancy focused on funding policy, governance, and sustainability strategies for education and human services organizations. Cari Maxwell  Cari was diagnosed with Polycystic Kidney Disease (PKD) in 1989. Through healthy living and choices, she managed her disease on her own for many years following the example of her father, who experienced ESRD in the early 1980s. A registered organ donor provided a near-perfect matching kidney to him and that gift of life granted Cari and her family 31 additional years with him before he passed away in October of 2018. Advancements in treatment for PKD patients are very close to Cari's heart, not only for herself but also for her other two siblings and oldest child that are diagnosed with ADPKD and for the likelihood that her two younger children may also be one day. She was fortunate to be able to participate in the clinical trial for the first-ever FDA-approved treatment for PKD – a treatment she still benefits from today. Cari is a member of the National Kidney Foundation's Kidney Advocacy Committee, and she champions patient education, early detection, and scientific advancement through patient-oriented clinical research. She hopes that through her commitment to the awareness of chronic kidney diseases, others will take an active role in their health journey through early detection, healthy choices, and becoming a strong voice of advocacy for themselves and others. Cari is a wife and mother to three daughters and works full-time as the Director of Culture & Operations for a growing technology integration firm near Hershey, PA.   For more information on pregnancy and kidney disease, visit https://www.kidney.org/atoz/content/pregnancy.

How can we improve the organ pool for kidney transplantation and how do we implement all alternatives in the current transplant teams? Dr. Oscar Rodriguez Faba is an associate member of the EAU Guidelines panel for kidney transplantation and talks about these questions in this podcast.Oscar Rodriguez Faba closes with the answer to the question if the results are comparable to cadaveric donors and conventional living donors.

FDA 批准靶向PDL1抑制剂成为尿路上皮癌的一线治疗Clin J Am Soc Nephr 老年捐赠者单肾和双肾移植的应用和结果LANCET 供氧冷灌注与标准冷灌注保存肾脏的临床研究Am J Kidney Dis ABO血型不匹配的活体肾移植对患者生存的影响Nature子刊 使用血浆和尿液无细胞DNA甲基化模式识别肾细胞癌阿维鲁单抗（avelumab）2020年7月，FDA批准PD-L1抑制剂阿维鲁单抗（avelumab）用于局部晚期或转移性尿路上皮癌患者的一线维持治疗。《JAVELIN Bladder 100研究：阿维鲁单抗用于晚期或转移性尿路上皮细胞癌的维持治疗》New England Journal of Medicine，2020年9月 (1)这项3期试验的目的是阿维鲁单抗用于化疗后尿路上皮癌患者的维持治疗的疗效。研究纳入局部晚期或转移性尿路上皮细胞癌，并且一线化疗（吉西他滨+顺铂或卡铂治疗4~6个周期）后未出现疾病进展的患者共700人，随机分入支持治疗组、或阿维鲁单抗维持治疗组。阿维鲁单抗维持性治疗显著延长了总生存期和无进展生存期。阿维鲁单抗与对照组相比，1年总生存率分别为71.3%和58.4%（中位总生存期，21.4个月vs. 14.3个月；风险比，0.69；P=0.001）；在PD-L1阳性人群中，阿维鲁单抗组和对照组相比，1年总生存率分别为79.1%和60.4%（风险比，0.56；P